Preparation of E-selectin-targeting nanoparticles and preliminary in vitro evaluation

Preparation of E-selectin-targeting nanoparticles and preliminary in vitro evaluation Article history: Targeted delivery aims to concentrate therapeutic agents at their site of action and thereby enhance Received 23 November 2011 treatment and limit side-effects. E-selectin on endothelial cells is markedly up-regulated by cytokine Received in revised form 11 January 2012 stimulation of inflamed and some tumoral tissues, promoting the adhesion of leukocytes and metastatic Accepted 13 January 2012 tumor cells, thus making it an interesting molecular target for drug delivery systems. Available online 23 January 2012 We report here the preparation of targeted nanoparticles from original amphiphilic block copolymers functionalized with an analog of sialyl Lewis X (SLEx), the physiological ligand of E-selectin. Nanoparticles, Keywords: prepared by nanoprecipitation, caused no significant cytotoxicity. Ligand-functionalized nanoparticles Carbohydrate ligand conjugated polymers were specifically recognized and internalized better by tumor necrosis factor  (TNF-)-activated human E-selectin umbilical vein endothelial cells (HUVECs) than control nanoparticles or HUVECs with low E-selectin HUVECs expression. These nanoparticles are designed to carry the ligand at the end of a PEG spacer to improve Nanoparticles accessibility. This system has potential for the treatment of inflammation, inhibition of tumor metastasis, and for molecular imaging. © 2012 Elsevier B.V. All rights reserved. 1. Introduction peptides (Myrset et al., 2011; Shamay http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Pharmaceutics Elsevier

Preparation of E-selectin-targeting nanoparticles and preliminary in vitro evaluation

Loading next page...
 
/lp/elsevier/preparation-of-e-selectin-targeting-nanoparticles-and-preliminary-in-ZRvYu0O9A3
Publisher
Elsevier
Copyright
Copyright © 2012 Elsevier B.V.
ISSN
0378-5173
D.O.I.
10.1016/j.ijpharm.2012.01.029
Publisher site
See Article on Publisher Site

Abstract

Article history: Targeted delivery aims to concentrate therapeutic agents at their site of action and thereby enhance Received 23 November 2011 treatment and limit side-effects. E-selectin on endothelial cells is markedly up-regulated by cytokine Received in revised form 11 January 2012 stimulation of inflamed and some tumoral tissues, promoting the adhesion of leukocytes and metastatic Accepted 13 January 2012 tumor cells, thus making it an interesting molecular target for drug delivery systems. Available online 23 January 2012 We report here the preparation of targeted nanoparticles from original amphiphilic block copolymers functionalized with an analog of sialyl Lewis X (SLEx), the physiological ligand of E-selectin. Nanoparticles, Keywords: prepared by nanoprecipitation, caused no significant cytotoxicity. Ligand-functionalized nanoparticles Carbohydrate ligand conjugated polymers were specifically recognized and internalized better by tumor necrosis factor  (TNF-)-activated human E-selectin umbilical vein endothelial cells (HUVECs) than control nanoparticles or HUVECs with low E-selectin HUVECs expression. These nanoparticles are designed to carry the ligand at the end of a PEG spacer to improve Nanoparticles accessibility. This system has potential for the treatment of inflammation, inhibition of tumor metastasis, and for molecular imaging. © 2012 Elsevier B.V. All rights reserved. 1. Introduction peptides (Myrset et al., 2011; Shamay

Journal

International Journal of PharmaceuticsElsevier

Published: Apr 15, 2012

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off